Larson Financial Group’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.17K Buy
201
+12
+6% +$380 ﹤0.01% 2684
2026
Q2
$5.19K Buy
189
+79
+72% +$2.1K ﹤0.01% 2757
2026
Q1
$2.95K Sell
110
-112
-50% -$3.36K ﹤0.01% 2840
2025
Q4
$6.84K Buy
222
+194
+693% +$6.05K ﹤0.01% 2326
2025
Q3
$859 Buy
+28
New +$682 ﹤0.01% 2962
2023
Q4
– Sell
-31
Closed -$1.09K – 1845
2023
Q3
$1.09K Buy
+31
New +$1.18K ﹤0.01% 1474

Other funds holding GMAB

Larson Financial Group's GMAB Position: Q3 2026 in Review

Larson Financial Group increased its Genmab (GMAB) stake by 6.3% in Q3 2026, buying an estimated $380 and bringing the position to 201 shares worth $7.17K. The position accounts for ﹤0.01% of the portfolio, ranked #2684.

Larson Financial Group first reported a position in GMAB in Q3 2023 and has held it in 6 quarters since. 331 funds tracked by Wall St. Rank hold GMAB as of Q3 2026.

  • Larson Financial Group held 201 shares of Genmab worth $7.17K as of Q3 2026.
  • Larson Financial Group bought 12 Genmab shares in Q3 2026, an estimated $380.
  • Genmab made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #2684 holding.
  • Larson Financial Group first reported a position in Genmab in Q3 2023 and has held it in 6 quarters since.
  • 331 funds tracked by Wall St. Rank held Genmab as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.